Type IV Protein Secretion in Helicobacter pylori
幽门螺杆菌中 IV 型蛋白的分泌
基本信息
- 批准号:10390377
- 负责人:
- 金额:$ 71.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-18 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimal ModelAntibiotic ResistanceAntibioticsArchitectureBacteriaBiological AssayCancer EtiologyCarcinogensCell Culture TechniquesCellsCessation of lifeChromosome MappingChronicClarithromycinClinicalComplexCryoelectron MicroscopyDNADiseaseDuodenal UlcerElementsEventExhibitsFundingGastric AdenocarcinomaGastric lymphomaGastric mucosaGastric ulcerGene ExpressionGenesGenetic TechniquesGoalsGram-Negative BacteriaHelicobacter InfectionsHelicobacter pyloriHelicobacter pylori induced gastric cancerHomologous GeneHumanIncidenceIndividualInfectionKnowledgeLeadLifeLinkMalignant - descriptorMapsMembraneMethodsMicrobeModelingMolecularMucositisN-terminalNucleotidesOncoproteinsOrganismOutcomePathogenicity IslandPathologicPeptic UlcerPersonsPhenotypeProtein SecretionProteinsResearchResistanceResolutionRhizobium radiobacterRisk FactorsRoleSignal TransductionStomachStomach DiseasesStructural ModelsStructureStructure-Activity RelationshipSymptomsSystemTestingTimeType IV Secretion System PathwayVariantVirulence FactorsWorkWorld Health Organizationalpha helixbasecarcinogenesisfitnessgenetic manipulationimprovedin vivomalignant stomach neoplasmmutantparticleperiplasmpersistent bacteriaprototyperecruitresponse
项目摘要
PROJECT SUMMARY (ABSTRACT)
Helicobacter pylori is a Gram-negative bacterium that colonizes the human stomach. H. pylori colonization of the
stomach results in chronic gastric mucosal inflammation and is a strong risk factor for gastric cancer and
duodenal or gastric ulceration. Gastric cancer is the third leading cause of cancer-related death worldwide, and
H. pylori has been classified as a type I carcinogen by the World Health Organization. The H. pylori CagA protein
is secreted through a type IV secretion system (T4SS), enters gastric cells, and causes alterations in cellular
signaling associated with malignant transformation. CagA and components of the Cag T4SS are encoded by
genes within a chromosomal region known as the cag pathogenicity island (PAI), which is present in some H.
pylori strains but not others. The incidence of symptomatic gastroduodenal disease (gastric cancer or peptic
ulceration) is higher among individuals infected with cag PAI-positive strains than among those infected with cag
PAI-negative strains. The molecular architecture and protein composition of the H. pylori Cag T4SS differ
substantially from corresponding features of T4SSs found in other bacterial species. The overarching long-term
goal of this research is to develop a better understanding of the molecular mechanisms by which H. pylori causes
gastric disease. During the previous funding period, we isolated a transmembrane core complex of the Cag
T4SS containing five proteins encoded by the cag PAI, described three main structural features of the complex
(outer membrane cap, periplasmic ring and stalk), and built partial models of three proteins within the complex.
The aims of the current proposal are i) to build a complete structural model of the five Cag T4SS core complex
components; ii) to define structure-function relationships for CagY (a core complex component predicted to span
from the inner membrane to the outer membrane), elucidating its role in CagA recruitment and T4SS activity;
and (iii) to define actions of the Cag T4SS in vivo. Methods will include single particle cryo-electron microscopy
analysis of the T4SS core complex, specialized techniques for genetic manipulation of H. pylori, cell culture-
based assays of Cag T4SS activity, and an animal model of H. pylori-induced gastric cancer. These studies will
provide important advances in our understanding of the molecular mechanisms by which H. pylori infection can
lead to gastric cancer and other gastric diseases. On a broader scope, these studies will increase our
understanding of bacterial secretion systems and the delivery of bacterial virulence factors into host cells, as
well as molecular mechanisms underlying microbe-induced carcinogenesis.
项目概要(摘要)
幽门螺杆菌是一种革兰氏阴性细菌,定植在人类胃中。H.幽门螺杆菌定植
胃导致慢性胃粘膜炎症,是胃癌的一个强危险因素,
十二指肠或胃溃疡。胃癌是全球癌症相关死亡的第三大原因,
H.幽门螺杆菌已被世界卫生组织归类为I型致癌物。螺杆幽门螺杆菌CagA蛋白
通过IV型分泌系统(T4 SS)分泌,进入胃细胞,并引起细胞内
与恶性转化相关的信号传导。CagA和CagT 4SS的组分由以下编码:
基因位于一个被称为cag致病岛(派)的染色体区域内,它存在于一些H.
pylori菌株而不是其他菌株。症状性胃十二指肠疾病(胃癌或消化性溃疡)的发病率
溃疡)在感染cag PAI阳性菌株的个体中高于感染cag的个体
PAI阴性菌株。对该菌的分子结构和蛋白质组成进行了研究。pylori Cag T4 SS差异
基本上与在其他细菌物种中发现的T4 SS的相应特征不同。总体长期
本研究的目的是更好地了解H.幽门螺杆菌病因
胃病。在上一个资助期间,我们分离了Cag的跨膜核心复合物,
T4 SS含有cag派编码的5个蛋白,描述了该复合物的3个主要结构特征
(外膜帽,周质环和柄),并建立了部分模型的三个蛋白质的复合物。
本提案的目的是:i)建立五个Cag T4 SS核心复合体的完整结构模型
ii)定义CagY(预测跨越的核心复合物组分)的结构-功能关系
从内膜到外膜),阐明其在CagA募集和T4 SS活性中的作用;
和(iii)确定Cag T4 SS在体内的作用。方法将包括单粒子冷冻电子显微镜
T4 SS核心复合物的分析,H.幽门螺杆菌,细胞培养-
CagT 4SS活性测定和H.幽门诱发胃癌这些研究将
为我们理解H.幽门螺杆菌感染可
导致胃癌和其他胃疾病。在更广泛的范围内,这些研究将增加我们的
了解细菌分泌系统和细菌毒力因子进入宿主细胞的传递,
以及微生物致癌的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY L COVER其他文献
TIMOTHY L COVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY L COVER', 18)}}的其他基金
Type IV Protein Secretion in Helicobacter pylori
幽门螺杆菌中 IV 型蛋白的分泌
- 批准号:
10595676 - 财政年份:2016
- 资助金额:
$ 71.49万 - 项目类别:
Type IV Protein Secretion in Helicobacter pylori
幽门螺杆菌中 IV 型蛋白的分泌
- 批准号:
10218960 - 财政年份:2016
- 资助金额:
$ 71.49万 - 项目类别:
Helicobacter pylori cag Pathogenicity Island and Gastric Carcinogenesis
幽门螺杆菌致病岛与胃癌发生
- 批准号:
8413059 - 财政年份:2013
- 资助金额:
$ 71.49万 - 项目类别:
Regulation of H. Pylori Virulance by Dietary Factors that Impact Gastric Cancer
影响胃癌的饮食因素对幽门螺杆菌毒力的调节
- 批准号:
9274163 - 财政年份:2009
- 资助金额:
$ 71.49万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 71.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists